Communication support for ventilated intensive care patients
Communication Enhancement Among Ventilated Patients in Intensive Care : Feasibility of Implementing "JIB-TourS cARe" High Technology Device With Eye Tracker
This project will try an eye-tracking tablet (JIB-Tours care) to help conscious, ventilated adults in ICU who cannot speak communicate with caregivers and family.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Tours Academic / other |
| Locations | 3 sites (Le Mans and 2 other locations) |
| Trial ID | NCT07251530 on ClinicalTrials.gov |
What this trial studies
JIB-Tours care is a tablet-based communication system controlled by eye-tracking that first runs a brief test to determine a patient’s comprehension level and then automatically selects one of three tailored communication interfaces. The device is intended for conscious, intubated or tracheostomized adult ICU patients who can open and close their eyes on command. The observational program will implement the system at participating ICUs and record whether the comprehension test can be completed, the interface switches correctly, and patients can deliver intended messages. The system was co-designed with ICU clinicians, former patients, and relatives to match real-world needs.
Who should consider this trial
Good fit: Conscious adult ICU patients who are intubated or have an inflated-cuff tracheostomy, can open and close their eyes on command, and speak French.
Not a fit: Patients with uncorrected visual or hearing impairments, reduced consciousness, non-French speakers, or those under legal guardianship are unlikely to benefit from this system.
Why it matters
Potential benefit: If successful, it could allow non-speaking ventilated patients to express needs and feelings more reliably, lowering anxiety and improving care decisions.
How similar studies have performed: Previous small pilots of eye-tracking and augmentative communication in critical care have shown feasibility and improved patient communication, but larger controlled evidence remains limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Intubated ventilated ICU patient * Hospitalized patient with an inflated cuff tracheostomy * conscious patient, able to open and close eyes on demand * of-age patient * French speaking Exclusion Criteria: * Patient with uncorrected visual impairment or hearing deficiency * Known guardianship or trusteeship at the time of inclusion * Known pregnant women at the time of inclusion and lactating patients * opposed to the processing of personal data
Where this trial is running
Le Mans and 2 other locations
- Intensive care, Hospital, Le MANS — Le Mans, France (Not_yet_recruiting)
- Intensive care, University Hospital, Orléans — Orléans, France (Not_yet_recruiting)
- Intensive care, University Hospital — Tours, France (Recruiting)
Study contacts
- Principal investigator: Laetitia BODET-CONTENTIN, MD PhD — Intensive care, University Hospital, Tours
- Study coordinator: Laetitia BODET-CONTENTIN, Doctor
- Email: laetitia.bodet@chu-tours.fr
- Phone: 0247479861
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.